Factors affecting axillary lymph node retrieval and assessment in breast cancer patients

Annals of Surgical Oncology

Volumn 15, Issue 12, 2008, Pages 3361-3368

  Cil, T ^a   Hauspy, J ^b   Kahn, H ^a   Gardner, S ^a   Melnick, W ^a   Flynn, C ^a   Holloway, C M B ^a  

^a SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^b MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER GRADING; CANCER PATIENT; CLINICAL DECISION MAKING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; FEMALE; HUMAN; HUMAN CELL; LYMPH NODE BIOPSY; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MULTIVARIATE ANALYSIS; OUTCOME ASSESSMENT; RANDOMIZED CONTROLLED TRIAL; SENTINEL LYMPH NODE BIOPSY; UNIVARIATE ANALYSIS;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; AXILLA; BREAST NEOPLASMS; FEMALE; HUMANS; LYMPH NODE EXCISION; LYMPH NODES; LYMPHATIC METASTASIS; MIDDLE AGED; NEOPLASM STAGING; RETROSPECTIVE STUDIES; SENTINEL LYMPH NODE BIOPSY;

EID: 58149311238     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-008-9938-6     Document Type: Article

References (29)

1. A Jemal R Siegel E Ward 2007 Cancer statistics, 2007 CA Cancer J Clin 57 43 66
2. The Steering Committee on Clinical Practice. Guidelines for the Care and Treatment of Breast Cancer. CMAJ 1998; 158 Suppl 3:S1-2
3. D Mirsky SE O'Brien DR McCready 1997 Surgical management of early stage invasive breast cancer (stage I and II) Provincial Breast Disease Site Group. Cancer Prev Control 1 10 7
4. P Eifel JA Axelson J Costa 2001 National Institutes of Health Consensus Development Conference Statement: adjuvant therapy for breast cancer, November 1-3, 2000 J Natl Cancer Inst 93 979 89
5. B Fisher N Wolmark M Bauer 1981 The accuracy of clinical nodal staging and of limited axillary dissection as a determinant of histologic nodal status in carcinoma of the breast Surg Gynecol Obstet 152 765 72
6. L Weir C Speers Y D'Yachkova 2002 Prognostic significance of the number of axillary lymph nodes removed in patients with node-negative breast cancer J Clin Oncol 20 1793 9
7. GH Sakorafas AG Tsiotou BM Balsiger 2000 Axillary lymph node dissection in breast cancer-current status and controversies, alternative strategies and future perspectives Acta Oncol 39 455 66
8. B Fowble LJ Solin DJ Schultz 1989 Frequency, sites of relapse, and outcome of regional node failures following conservative surgery and radiation for early breast cancer Int J Radiat Oncol Biol Phys 17 703 10
9. RK Orr 1999 The impact of prophylactic axillary node dissection on breast cancer survival-a Bayesian meta-analysis Ann Surg Oncol 6 109 16
10. CL Carter C Allen DE Henson 1989 Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases Cancer 63 181 7
11. R Chaudhry V Goel C Sawka 2001 Breast cancer survival by teaching status of the initial treating hospital CMAJ 164 183 8
12. JA Sosa M Diener-West Y Gusev 1998 Association between extent of axillary lymph node dissection and survival in patients with stage I breast cancer Ann Surg Oncol 5 140 9
13. J Kjaergaard M Blichert-Toft JA Andersen 1985 Probability of false negative nodal staging in conjunction with partial axillary dissection in breast cancer Br J Surg 72 365 7
14. O Mathiesen J Carl O Bonderup 1990 Axillary sampling and the risk of erroneous staging of breast cancer. An analysis of 960 consecutive patients Acta Oncol 29 721 5
15. CK Axelsson HT Mouridsen K Zedeler 1992 Axillary dissection of level I, II lymph nodes is important in breast cancer classification. The Danish Breast Cancer Cooperative Group (DBCG) Eur J Cancer 28A 1415 8
16. M Van Lancker C Goor R Sacre 1995 Patterns of axillary lymph node metastasis in breast cancer Am J Clin Oncol 18 267 72
17. B Fisher NH Slack 1970 Number of lymph nodes examined and the prognosis of breast carcinoma Surg Gynecol Obstet 131 79 88
18. JC Rageth P Wyss C Unger 1996 Axillary lymphadenectomy-just how radical should it be? Surg Oncol 5 37 41
19. RE Mansel L Fallowfield M Kissin 2006 Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC trial J Natl Cancer Inst 98 599 609
20. A Fleissig LJ Fallowfield CI Langridge 2006 Post-operative arm morbidity and quality of life. Results of the ALMANAC randomised trial comparing sentinel node biopsy with standard axillary treatment in the management of patients with early breast cancer Breast Cancer Res Treat 95 279 93
21. PG Moorman A Hamza JR Marks 2001 Prognostic significance of the number of lymph nodes examined in patients with lymph node-negative breast carcinoma Cancer 91 2258 62
22. DW Petrik DR McCready CA Sawka 2003 Association between extent of axillary lymph node dissection and patient, tumor, surgeon, and hospital factors in patients with early breast cancer J Surg Oncol 82 84 90
23. M Schaapveld R Otter EG de Vries 2004 Variability in axillary lymph node dissection for breast cancer J Surg Oncol 87 4 12
24. NJ Bundred DA Morgan JM Dixon 1994 ABC of breast diseases. Management of regional nodes in breast cancer BMJ 309 1222 5
25. Littell RC, Milliken GA, Stroup WW, et al. SAS System for Mixed Models. Cary, NC: SAS Institute Inc., 1996
26. R Xu 2003 Measuring explained variation in linear mixed effects models Stat Med 22 3527 41
27. KY Liang SL Zeger 198 Longitudinal data analysis using generalized linear models Biometrika 6 13 22
28. DA Braunholtz SJ Edwards RJ Lilford 2001 Are randomized clinical trials good for us (in the short term)? Evidence for a "trial effect" J Clin Epidemiol 54 217 24
29. HW Palamba MC Rombouts THM Ruers 2001 Extranodal extension of axillary metastasis of invasive breast carcinoma as a possible predictor for the total number of positive lymph nodes Eur J Surg Oncol 8 719 22